6,016 Shares in Medtronic PLC $MDT Acquired by Legacy Advisory Services LLC

Key Points

• Legacy Advisory Services LLC has acquired a new stake in Medtronic PLC, purchasing 6,016 shares valued at approximately $541,000 during the 1st quarter, making it the firm's 23rd largest holding.
• Medtronic's stock has been primarily influenced by institutional activity, with 82.06% of the company's stock owned by institutional investors and hedge funds.
• The company recently announced a quarterly dividend of $0.71, yielding 3.1%, and its FY 2026 earnings guidance is set at 5.600-5.660 EPS.

Legacy Advisory Services LLC purchased a new position in shares of Medtronic PLC (NYSE:MDT - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 6,016 shares of the medical technology company's stock, valued at approximately $541,000. Medtronic accounts for approximately 0.5% of Legacy Advisory Services LLC's investment portfolio, making the stock its 23rd biggest position.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Commerce Bank boosted its position in shares of Medtronic by 1.7% in the 1st quarter. Commerce Bank now owns 145,984 shares of the medical technology company's stock worth $13,118,000 after buying an additional 2,429 shares in the last quarter. Brighton Jones LLC boosted its position in shares of Medtronic by 1,368.0% in the 4th quarter. Brighton Jones LLC now owns 39,989 shares of the medical technology company's stock worth $3,194,000 after buying an additional 37,265 shares in the last quarter. RNC Capital Management LLC boosted its position in shares of Medtronic by 8.8% in the 1st quarter. RNC Capital Management LLC now owns 417,021 shares of the medical technology company's stock worth $37,474,000 after buying an additional 33,729 shares in the last quarter. Insight Inv LLC boosted its position in shares of Medtronic by 84.2% in the 1st quarter. Insight Inv LLC now owns 27,456 shares of the medical technology company's stock worth $2,467,000 after buying an additional 12,550 shares in the last quarter. Finally, Korea Investment CORP boosted its position in shares of Medtronic by 24.1% in the 1st quarter. Korea Investment CORP now owns 1,141,565 shares of the medical technology company's stock worth $102,581,000 after buying an additional 221,568 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

MDT has been the topic of several recent research reports. Evercore ISI boosted their price objective on shares of Medtronic from $103.00 to $106.00 and gave the stock an "outperform" rating in a research report on Tuesday, July 8th. BTIG Research reiterated a "neutral" rating on shares of Medtronic in a research report on Friday, July 11th. Wall Street Zen upgraded shares of Medtronic from a "hold" rating to a "buy" rating in a research report on Saturday, August 30th. Mizuho boosted their price objective on shares of Medtronic from $98.00 to $100.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 16th. Finally, William Blair upgraded shares of Medtronic to a "hold" rating in a report on Friday, July 11th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and eight have assigned a Hold rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $102.14.

Insider Transactions at Medtronic

In other news, EVP Harry Skip Kiil sold 8,605 shares of the company's stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $91.58, for a total transaction of $788,045.90. Following the completion of the transaction, the executive vice president owned 35,615 shares of the company's stock, valued at $3,261,621.70. This represents a 19.46% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director William R. Jellison acquired 2,500 shares of the company's stock in a transaction dated Monday, August 25th. The shares were bought at an average cost of $92.37 per share, with a total value of $230,925.00. Following the purchase, the director owned 5,000 shares in the company, valued at approximately $461,850. The trade was a 100.00% increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 0.26% of the company's stock.

Medtronic Trading Down 0.2%

NYSE:MDT traded down $0.20 on Friday, reaching $94.05. The stock had a trading volume of 7,334,188 shares, compared to its average volume of 7,590,054. Medtronic PLC has a 12-month low of $79.29 and a 12-month high of $96.25. The firm's fifty day moving average is $91.39 and its two-hundred day moving average is $88.26. The company has a debt-to-equity ratio of 0.54, a current ratio of 2.01 and a quick ratio of 1.50. The company has a market cap of $120.64 billion, a price-to-earnings ratio of 25.91, a P/E/G ratio of 2.43 and a beta of 0.77.

Medtronic (NYSE:MDT - Get Free Report) last posted its quarterly earnings data on Tuesday, August 19th. The medical technology company reported $1.26 EPS for the quarter, beating analysts' consensus estimates of $1.23 by $0.03. Medtronic had a net margin of 13.63% and a return on equity of 14.61%. The company had revenue of $8.58 billion during the quarter, compared to the consensus estimate of $8.37 billion. During the same quarter in the prior year, the company posted $1.23 EPS. The company's quarterly revenue was up 7.7% compared to the same quarter last year. Medtronic has set its FY 2026 guidance at 5.600-5.660 EPS. Equities analysts expect that Medtronic PLC will post 5.46 EPS for the current fiscal year.

Medtronic Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 17th. Stockholders of record on Friday, September 26th will be paid a dividend of $0.71 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $2.84 dividend on an annualized basis and a dividend yield of 3.0%. Medtronic's dividend payout ratio is currently 78.24%.

Medtronic Profile

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.